Lack of efficacy of adjuvant lapatinib in HER2-negative breast cancer (HER2–ve BC): Analysis of patients in the TEACH trial.
Yanin Chavarri Guerra
No relevant relationships to disclose
Arlene Chan
Research Funding - Amgen
Dianne M. Finkelstein
Consultant or Advisory Role - Amgen; Johnson & Johnson
Valorie F. Chan
No relevant relationships to disclose
Vernon J. Harvey
Honoraria - Roche; Sanofi
Research Funding - Roche
Keun Seok Lee
No relevant relationships to disclose
Minish Mahendra Jain
No relevant relationships to disclose
Katarina Petrakova
No relevant relationships to disclose
Vinod Raina
No relevant relationships to disclose
Binghe Xu
No relevant relationships to disclose
Henry Gomez
No relevant relationships to disclose
Erica Rappold
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Tomomi Kaneko
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Yingjie Huang
Employment or Leadership Position - GlaxoSmithKline
Paul E. Goss
Honoraria - Pfizer